FDA Rejects “Not Approvable” Letters, Clarifies Efficacy Supplement

FDA says industry concerns about the implied finality of "not approvable" letters led it to change how it responds to drug applications

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet